Valeant Names Perrigo's Papa as CEO to Lead Turnaround
- Drugmaker has been searching for a new CEO since March
- Papa joined Perrigo in 2006, fended off hostile bid from Mylan
Perrigo's Papa Leaves to Lead Valeant as New CEO
This article is for subscribers only.
Valeant Pharmaceuticals International Inc. hired Perrigo Co. CEO Joseph Papa as its new chief executive officer and chairman, tasking him with turning around an embattled drugmaker that has faced multiple setbacks over the past months.
Papa will start in early May, Valeant said in a statement Monday. The 60-year-old executive has more than 35 years of experience in the pharmaceutical and health-care services industries, including 20 years at branded prescription drugmakers, Valeant said.